Jefferey Donnell - BioQuest Corp Chief Director

BQST Stock

USD 1.12 0.02 1.82%

Insider

Jefferey Donnell is Chief Director of BioQuest Corp

Age	72
Phone	714 978 4425
Web	https://www.bioquestcorp.com

BioQuest Corp Management Efficiency

The company has return on total asset (ROA) of (17.3134) % which means that it has lost $17.3134 on every $100 spent on assets. This is way below average. BioQuest Corp's management efficiency ratios could be used to measure how well BioQuest Corp manages its routine affairs as well as how well it operates its assets and liabilities.

Compare BioQuest Corp to Peers

Predict price of BioQuest Corp

BioQuest Corp currently holds 183.3 K in liabilities with Debt to Equity (D/E) ratio of 0.8, which is about average as compared to similar companies. BioQuest Corp has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioQuest Corp until it has trouble settling it off, either with new capital or with free cash flow. So, BioQuest Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioQuest Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioQuest to invest in growth at high rates of return. When we think about BioQuest Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Joao Aguilar	Hypera SA	N/A
	Mario Tabraue	Earth Science Tech	44
	Marianne Velasco	Genomma Lab Internacional	N/A
	Cindy Patton	Cumberland Pharmaceuticals	71
	Juliana Salem	Hypera SA	N/A
	Adam Mostafa	Cumberland Pharmaceuticals	44
	Jorge Valderrama	Genomma Lab Internacional	N/A
	Adalmario Couto	Hypera SA	N/A
	Mximo Juda	Genomma Lab Internacional	N/A
	Engineer Galland	Genomma Lab Internacional	N/A
	Alejandro Patio	Genomma Lab Internacional	N/A
	A MBA	Cumberland Pharmaceuticals	66
	Hlio Segouras	Hypera SA	N/A
	L Porres	Genomma Lab Internacional	N/A
	Luiz Clavis	Hypera SA	N/A
	Mauricio Christovam	Hypera SA	N/A
	Daniel Neria	Genomma Lab Internacional	N/A
	Juan Sparvieri	Genomma Lab Internacional	N/A
	Efran Crdova	Genomma Lab Internacional	N/A
	Robert Stevens	Earth Science Tech	56

BioQuest Corp. intends to acquire companies in green energy sector in the United States. BioQuest Corp. was incorporated in 2011 and is based in Newport Beach, California. BIOQUEST CORP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 7 people. BioQuest Corp [BQST] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Return On Asset

-17.31

BioQuest Corp Leadership Team

Elected by the shareholders, the BioQuest Corp's board of directors comprises two types of representatives: BioQuest Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioQuest. The board's role is to monitor BioQuest Corp's management team and ensure that shareholders' interests are well served. BioQuest Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioQuest Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Jefferey Donnell, Chief Director
	Michael Krall, Pres COO
	Pamela Daily, Chief Officer
	Thomas Hemingway, Chairman CEO
	David Noyes, Chief Officer

BioQuest Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is BioQuest Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Asset	-17.31
	Current Valuation	1.68 M
	Shares Outstanding	11.49 M
	Shares Owned By Insiders	88.67 %
	Price To Book	0.35 X
	Price To Sales	52.71 X
	Gross Profit	(467.57 K)
	EBITDA	(718.31 K)
	Net Income	(821.02 K)
	Cash And Equivalents	14.96 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioQuest Pink Sheet Analysis

When running BioQuest Corp's price analysis, check to measure BioQuest Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioQuest Corp is operating at the current time. Most of BioQuest Corp's value examination focuses on studying past and present price action to predict the probability of BioQuest Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioQuest Corp's price. Additionally, you may evaluate how the addition of BioQuest Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC